A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)
Keywords: لیپیدو استروفی اچ آی وی; facial volume loss; filler agent; highly active antiretroviral therapy; HIV facial lipoatrophy; HIV lipodystrophy; quality of life; AFT; autologous fat transfer; CaHA; calcium hydroxylapatite; FDA; Food and Drug Administration; FLA; facial lipoatrophy; GO